Yup, mass vaccination is the key here. Once the new integrated device is done testing, it'll be used for US troops around the world. Big, free $$ will flow to INO from the US govt
PLYMOUTH MEETING, Pa. , Jan. 19, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today it has been selected to receive a $500,000 grant from the U.S. Army’s Small Business Innovation Research (SBIR) program to further advance the development of Inovio’s next generation delivery device capable of simultaneously administering multiple vaccines via a skin-surface, needle-free electroporation delivery.
The primary goal of this U.S. Army -funded effort is to further develop a device that would facilitate rapid vaccination of U.S. troops stationed around the world against multiple infectious diseases and protect civilian populations from pandemic threats. The new needle-free device could be used to deliver Inovio’s portfolio of biodefense and commercial infectious disease vaccines including those for MERS, Ebola, HIV, influenza, and RSV. Today’s grant is a follow-on to previous grants from the US Department of Defense . Initial testing of a prototype design has already yielded excellent antigen expression and immunogenicity from the dermal tissue being accessed using this novel non-invasive electroporation delivery concept.
INO will use the recent $500K Grant to 'integrate' the needle free device that would be a paradigm-changing step in vaccine administration in large population. Great deal, imo
Why adding the value...looks like most ppl missing this from the pr. Key word: Intergrated
Inovio is advancing multiple novel cancer and infectious disease immunotherapies and vaccines as well as delivery devices to optimally administer them. Since administration of Inovio’s products is a two-step process involving injection and electroporation delivery, it is also focused on enhancing ease and cost of administration to best serve clinical requirements. An integrated injection and electroporation device that eliminates needles and reduces disposable materials in an automated process would be a paradigm-changing step in vaccine administration in large populations.
Adding the Value...
My biggest one is the announcement of VGX-3100 got approval to move to P3 under the partnership of MedIm
MedIm will cover all cost for P3 to commercial of the product. INO get $100M upfront payment and double loyalty
Yes, Alex. this is Huge news to me. Getting Hep C running with no cost and under Mayo...
Wow, Great work, Dr Kim (sorry for my rant in the past...)
Hep C success in just P1 could lead to the hostile Buyout by BP...it had happened to few other small Bio companies in the last few years.
When INO stock price in $50 range, can all of us meet at some place, then we all travel to the poorest countries in Asia, Africa... to help all the poor ppl there, especially the children
Not sure why human being recently getting more and more of rare diseases...maybe due to change of environment, climate, chemical released from development countries that have not controlled properly, etc...Scary...
I tend to agree that INO could push more focus on the Infectious disease program and could very well be a dominant player for long time...
LOS ANGELES, April 22 (UPI) -- The cancer immunotherapy drug pembrolizumab, marketed as Keytruda, was shown to have longer-lasting anti-cancer effects and fewer overall side effects than other standard treatments for advanced melanoma, according to researchers.
The Illinois Department of Public Health said on Wednesday that five more people had died after being infected with Elizabethkingia, a disease linked to the deaths of 15 people in neighboring Wisconsin.
The cause of death was not identified as Elizabethkingia because many of those people had underlying health conditions, the department said. Ten Illinois residents have been diagnosed with Elizabethkingia, and six have died.
Hope INO can develop the vaccine to treat and prevent for this kind of disease
%^& cat - take a break here or there and take a bath if you have a chance...you smell so bad
Not sure anyone that could proudly themselves as being used as the 'tool'.
Everyone that on the msb knowing you're a tool. No more, no less.
Understand everyone must work to make the living...even w/ this kind of tool work. Shame on you.
Games being played by HFs...shorts it down, then raise it up, repeat...U can buy some at this level, then set to sell at $3-3.20. This is for short term play, imo.
Better long term is INO
They use this aacr to present the P1 interim data for prostate cancer...so they could literately not need to do the pr...save some $$ :)